Market Closed -
Nyse
04:00:02 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
30.21
USD
|
-2.49%
|
|
+0.97%
|
+91.44%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
188.6
|
448.4
|
1,647
|
780.2
|
1,204
|
2,359
|
-
|
-
|
Enterprise Value (EV)
1 |
188.1
|
435.6
|
1,647
|
780.2
|
1,180
|
2,398
|
2,687
|
2,790
|
P/E ratio
|
-12.9
x
|
-20.1
x
|
-40.8
x
|
-5.61
x
|
-23.9
x
|
372
x
|
46.1
x
|
26
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.35
x
|
4.47
x
|
13.5
x
|
4.33
x
|
5.04
x
|
5.96
x
|
4.21
x
|
3.16
x
|
EV / Revenue
|
1.35
x
|
4.34
x
|
13.5
x
|
4.33
x
|
4.94
x
|
6.06
x
|
4.79
x
|
3.74
x
|
EV / EBITDA
|
-1,075
x
|
-68.4
x
|
-63.4
x
|
-12.9
x
|
-51.4
x
|
39.5
x
|
22
x
|
15.5
x
|
EV / FCF
|
-59.4
x
|
-32.7
x
|
-50.8
x
|
-2.86
x
|
-5.41
x
|
-45
x
|
-13.3
x
|
-1,787
x
|
FCF Yield
|
-1.68%
|
-3.06%
|
-1.97%
|
-34.9%
|
-18.5%
|
-2.22%
|
-7.52%
|
-0.06%
|
Price to Book
|
3.2
x
|
6.84
x
|
11.8
x
|
1.05
x
|
2.47
x
|
4.55
x
|
4.08
x
|
3.78
x
|
Nbr of stocks (in thousands)
|
24,300
|
26,868
|
33,079
|
66,173
|
76,318
|
76,161
|
-
|
-
|
Reference price
2 |
7.760
|
16.69
|
49.79
|
11.79
|
15.78
|
30.21
|
30.21
|
30.21
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/15/23
|
2/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
139.4
|
100.3
|
121.6
|
180.4
|
238.7
|
395.8
|
561.1
|
745.7
|
EBITDA
1 |
-0.175
|
-6.367
|
-25.98
|
-60.64
|
-22.93
|
60.69
|
121.9
|
180
|
EBIT
1 |
-14.16
|
-21.57
|
-40.6
|
-79.24
|
-49.2
|
16.73
|
69.47
|
127.4
|
Operating Margin
|
-10.16%
|
-21.51%
|
-33.38%
|
-43.94%
|
-20.61%
|
4.23%
|
12.38%
|
17.09%
|
Earnings before Tax (EBT)
1 |
-14.56
|
-21.81
|
-37.09
|
-82.74
|
-45.81
|
7.506
|
53.6
|
100.4
|
Net income
1 |
-14.56
|
-21.81
|
-37.09
|
-82.74
|
-45.81
|
6.058
|
50.5
|
90.95
|
Net margin
|
-10.45%
|
-21.75%
|
-30.5%
|
-45.87%
|
-19.19%
|
1.53%
|
9%
|
12.2%
|
EPS
2 |
-0.6000
|
-0.8300
|
-1.220
|
-2.100
|
-0.6600
|
0.0811
|
0.6556
|
1.160
|
Free Cash Flow
1 |
-3.166
|
-13.34
|
-32.41
|
-272.4
|
-218.1
|
-53.3
|
-201.9
|
-1.562
|
FCF margin
|
-2.27%
|
-13.3%
|
-26.64%
|
-151.01%
|
-91.35%
|
-13.47%
|
-35.99%
|
-0.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/15/23
|
2/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
31.48
|
38.41
|
45.64
|
36.71
|
59.61
|
45.59
|
48.16
|
60.76
|
84.22
|
94.5
|
101.5
|
101.9
|
97.86
|
118.2
|
131.6
|
EBITDA
1 |
-12.15
|
-14.67
|
-18.32
|
-23.19
|
-4.464
|
-13.94
|
-10.83
|
-7.295
|
9.132
|
12.93
|
16.55
|
16.31
|
14.9
|
26.08
|
32.21
|
EBIT
1 |
-16.31
|
-18.62
|
-22.65
|
-28.31
|
-9.666
|
-18.91
|
-17.04
|
-14.63
|
1.383
|
5.138
|
6.042
|
5.05
|
2.772
|
10.8
|
14.6
|
Operating Margin
|
-51.83%
|
-48.49%
|
-49.62%
|
-77.12%
|
-16.22%
|
-41.48%
|
-35.39%
|
-24.09%
|
1.64%
|
5.44%
|
5.95%
|
4.95%
|
2.83%
|
9.14%
|
11.1%
|
Earnings before Tax (EBT)
1 |
-16.35
|
-19.48
|
-24.05
|
-29.6
|
-9.609
|
-16.8
|
-15.42
|
-13.07
|
-0.519
|
-1.079
|
4.533
|
3.528
|
0.6866
|
8.1
|
11.8
|
Net income
1 |
-16.35
|
-19.48
|
-24.05
|
-29.6
|
-9.609
|
-16.8
|
-15.42
|
-13.07
|
-0.519
|
-1.835
|
3.945
|
3.171
|
0.3996
|
8.686
|
13.21
|
Net margin
|
-51.96%
|
-50.73%
|
-52.7%
|
-80.63%
|
-16.12%
|
-36.84%
|
-32.03%
|
-21.52%
|
-0.62%
|
-1.94%
|
3.89%
|
3.11%
|
0.41%
|
7.35%
|
10.04%
|
EPS
2 |
-0.5000
|
-0.5900
|
-0.6800
|
-0.7500
|
-0.2000
|
-0.2400
|
-0.2200
|
-0.1900
|
-0.0100
|
-0.0200
|
0.0522
|
0.0411
|
0.005560
|
0.0900
|
0.1450
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/17/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/15/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/12/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
38.7
|
328
|
431
|
Net Cash position
1 |
0.51
|
12.8
|
-
|
-
|
24.7
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.6376
x
|
2.688
x
|
2.393
x
|
Free Cash Flow
1 |
-3.17
|
-13.3
|
-32.4
|
-272
|
-218
|
-53.3
|
-202
|
-1.56
|
ROE (net income / shareholders' equity)
|
-22.5%
|
-34.4%
|
-21.1%
|
-28.9%
|
-9.79%
|
3.35%
|
9.1%
|
10.2%
|
ROA (Net income/ Total Assets)
|
-14.4%
|
-21.7%
|
-29.1%
|
-19.9%
|
-6.8%
|
4.45%
|
9.1%
|
5.4%
|
Assets
1 |
101.3
|
100.5
|
127.4
|
414.8
|
673.2
|
136.1
|
555
|
1,684
|
Book Value Per Share
2 |
2.430
|
2.440
|
4.220
|
11.30
|
6.380
|
6.650
|
7.410
|
8.000
|
Cash Flow per Share
2 |
-0.0400
|
-0.3800
|
-0.6100
|
-2.400
|
-0.6100
|
-0.2100
|
1.170
|
1.420
|
Capex
1 |
2.11
|
3.42
|
13.8
|
178
|
175
|
73.2
|
453
|
191
|
Capex / Sales
|
1.52%
|
3.41%
|
11.33%
|
98.67%
|
73.5%
|
18.48%
|
80.7%
|
25.58%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/15/23
|
2/12/24
|
-
|
-
|
-
|
Last Close Price
30.21
USD Average target price
28.8
USD Spread / Average Target -4.67% Consensus |
1st Jan change
|
Capi.
|
---|
| +91.44% | 2.36B | | +20.59% | 68.69B | | -1.02% | 49.19B | | +23.82% | 44.73B | | +30.26% | 28.24B | | +7.56% | 19.22B | | +10.55% | 16.68B | | -5.73% | 16.08B | | -21.45% | 15.62B | | -20.45% | 13.89B |
Other Specialty Chemicals
|